Advertisement

Topics

GlaxoSmithKline reports positive results from phase III trial of its two-drug HIV treatment

04:41 EDT 14 Jun 2018 | Proactive Investors

The GEMINI trials showed that HIV could be treated with a two-drug regimen, as opposed to the cocktail of three or more drugs which sufferers currently have to take

Original Article: GlaxoSmithKline reports positive results from phase III trial of its two-drug HIV treatment

NEXT ARTICLE

More From BioPortfolio on "GlaxoSmithKline reports positive results from phase III trial of its two-drug HIV treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...